InSitu Technologies Inc.

09/29/2026

https://www.linkedin.com/pulse/why-stent-securement-testing-matters-insitu-technologies-inc-cmajc

A stent has one job before it's even deployed: stay put on the balloon. Sounds simple.

09/22/2026

Explore a Celosia™ case involving direct stenting of a distal right coronary artery lesion. Swipe through the patient context, original angiography and reported immediate outcome.

09/17/2026

Three decades of cardiovascular device manufacturing, right here in Minnesota. This is where it all starts. We shipped cardiovascular and peripheral stents to over 40 countries. We're not done expanding.

09/10/2026

Stent Securement Pre-Treatment Demonstration
A look at our stent securement pre-treatment testing using our in-house catheterized vascular model (ASTM compliant). This demonstration simulates device tracking through a vascular pathway to evaluate the stent delivery system during advancement and withdrawal.

08/27/2026

ASTM F1929
Dye pe*******on testing introduces a liquid dye into the package under pressure or vacuum to drive it through any seal channel defects, which are then identified visually. It is particularly sensitive to channel defects and pinholes that a bubble test might miss, and it works well for porous packaging materials like Tyvek®, which is common in sterile medical device pouches.

08/05/2026

A look at how a drug-eluting stent (DES) is deployed in the Left Anterior Descending (LAD) artery, one of the most critical vessels in the heart.

08/04/2026

Meet our products!
Siro™
The Siro Drug Eluting Stent combines the U.S. patented Direct-Stent® design, the proven success of Sirolimus drug to reduce tissue ingrowth and proliferation, leading to reduced restenosis.

Celosia™
The Celosia Coronary Covered Stent is indicated for use in the treatment of free perforations, defined as free contrast extravasation into the pericardium, in native coronary vessels ≥2.25mm in diameter.

Silene™
A covered stent indicated for ruptures, dissections, fistulae, aneurysms and saphenous vein grafts.

AaRiss™
AaRiss™ drug-coated balloon catheter has undergone clinical trials for in-stent restenosis of coronary arteries, coronary bifurcation lesions, and intracranial atherosclerotic stenotic lesions, which have proven to inhibit restenosis while maintaining a high safety profile.

More at: https://insitu-tech.com/portfolio/

Dedicated to Extending Life and Improving Health Around the Globe.

07/28/2026

https://www.linkedin.com/pulse/closer-look-testing-behind-every-sterile-package-qqmtc/

At InSitu Technologies, package validation is a formal, multi-step process that follows ISO 11607, the international standard that governs sterile medical device packaging. The goal is straightforward: prove that the package keeps the device sterile from the moment it is sealed all the way to the mo